Imagen de Portada

Modeling potential cost‐effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Meredith M. Hoog, Hong Kan, Kristen A. Deger, Sonja Sorensen, Lisa M. Neff, Jay Patrick Bae, Emily Ruth Hankosky, Madhumita Murphy, Donna Mojdami, Ivan Houisse, Mack S. Harris
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Obesity
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Real‐world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity database
por: Emily R. Hankosky, et al.
Publicado: (2025)

Body composition changes during weight reduction with tirzepatide in the SURMOUNT ‐1 study of adults with obesity or overweight
por: Michelle Look, et al.
Publicado: (2025)

Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world ( STEER )
por: Lauren Wilson, et al.
Publicado: (2026)

Early‐Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials
por: Evgenia Gourgari, et al.
Publicado: (2025)

Correction to “Body composition changes during weight reduction with tirzepatide in the SURMOUNT ‐1 study of adults with obesity or overweight”
Publicado: (2025)

Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program
por: Beverly G. Tchang, et al.
Publicado: (2025)

Impact of lifestyle moderate‐to‐vigorous physical activity timing on glycemic control in sedentary adults with overweight/obesity and metabolic impairments
por: Antonio Clavero‐Jimeno, et al.
Publicado: (2024)

Improved health‐related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT ‐5 trial
por: Alpana P. Shukla, et al.
Publicado: (2025)

Long‐term cost‐effectiveness of tirzepatide for individuals with type 2 diabetes and comorbid obesity
por: Man Tang, et al.
Publicado: (2025)

Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT ‐1 to ‐4 trials
por: Domenica M. Rubino, et al.
Publicado: (2025)

The role of lifestyle in the impact of constant phthalate exposure on overweight and obesity: A longitudinal cohort study in China
por: Tongjun Guo, et al.
Publicado: (2025)

Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison
por: Emily R. Hankosky, et al.
Publicado: (2025)

The impact of lifestyle‐based weight loss in older adults with obesity on muscle and bone health: a balancing act
por: Tiffany M. Cortes, et al.
Publicado: (2025)

The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
por: Iskandar Idris, et al.
Publicado: (2025)

Real‐world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® database
por: Theresa Hunter Gibble, et al.
Publicado: (2025)

Musculoskeletal characteristics in older adults with overweight or obesity: INVEST in Bone Health trial baseline analysis
por: S. Delanie Lynch, et al.
Publicado: (2025)

Time to weight plateau with tirzepatide treatment in the SURMOUNT ‐1 and SURMOUNT ‐4 clinical trials
por: Deborah B. Horn, et al.
Publicado: (2025)

A systematic review of the effectiveness of attentional bias modification to support weight management in individuals who are overweight or obese
por: Catherine Heidi Seage
Publicado: (2024)

Potent incretin‐based therapy for obesity: A systematic review and meta‐analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety
por: Alberte Laura Oest Müllertz, et al.
Publicado: (2024)

Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study
por: Jamy D. Ard, et al.
Publicado: (2025)

Why do preconception and pregnancy lifestyle interventions demonstrate limited success in preventing overweight and obesity in children? A scoping review investigating intervention complexity, process evaluation components, and author interpretations
por: Kaat Philippe, et al.
Publicado: (2024)

Comment on “Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes”
por: Manish R. Bhise, et al.
Publicado: (2025)

Real‐world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic
por: Jason M. Samuels, et al.
Publicado: (2025)

Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: The Look AHEAD trial
por: Joanna Y. Gong, et al.
Publicado: (2025)

Development and validation of an eating behavior patient‐reported outcome measure in people living with obesity or overweight
por: Donald M. Bushnell, et al.
Publicado: (2025)

Does deciding not to participate in a lifestyle intervention for children with obesity affect the long‐term weight change?
por: Rasmus M. Jørgensen, et al.
Publicado: (2025)

Myocardial mechano‐energetic efficiency is not impaired in patients with metabolically healthy overweight and obesity
por: Chiara Maria Assunta Cefalo, et al.
Publicado: (2024)

Maternal folic acid supplementation during pregnancy in association with childhood overweight or obesity
por: Chi‐Yen Hung, et al.
Publicado: (2024)

β‐alanine supplementation in adults with overweight and obesity: a randomized controlled feasibility trial
por: Joseph J. Matthews, et al.
Publicado: (2025)

Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life
por: Jia‐Jie Wang, et al.
Publicado: (2024)

Prevalence of overweight and obesity in incarcerated individuals in developed and developing countries: A systematic review and meta‐analysis
por: Leonida Nyarwaba Mosomi, et al.
Publicado: (2025)

Food insecurity and weight‐loss efforts among a nationally representative sample of US adults with higher weight
por: Kirstie M. Herb Neff
Publicado: (2024)

Psychological well‐being and the reversal of childhood overweight and obesity in the UK : a longitudinal national cohort study
por: I Gusti Ngurah Edi Putra, et al.
Publicado: (2024)

Exercise and diet effects on delay discounting and related neurobiology in adults with overweight or obesity: A randomized trial
por: Kelly T. Cosgrove, et al.
Publicado: (2025)

Exploring the perceptions of Chinese adults toward overweight and obesity: A systematic literature review
por: Yixi Wang‐Chen, et al.
Publicado: (2025)

Neurological‐related proteomic profiling in plasma of children with metabolic healthy and unhealthy overweight/obesity
por: Marcos Olvera‐Rojas, et al.
Publicado: (2024)

Impact of COVID‐19 pandemic on sleep parameters and characteristics in individuals living with overweight and obesity
por: Stephen A. Glazer, et al.
Publicado: (2024)

Clinical practice guidelines for the management of overweight and obesity published internationally: A scoping review
por: Cadeyrn J. Gaskin, et al.
Publicado: (2024)

Exploring potential reach and representativeness of a self‐weighing weight gain prevention intervention in adults with overweight and obesity
por: Kellie B. Scotti, et al.
Publicado: (2024)

Metabolic outcomes of bariatric surgery versus lifestyle intervention in adolescents with severe obesity: A systematic review and meta‐analysis
por: A. B. M. Kamrul‐Hasan, et al.
Publicado: (2025)